Castle Biosciences Inc
CSTL40.090USD
-0.110-0.27%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.17BMarket Cap
LossP/E TTM
Castle Biosciences Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
332.07M
51.09%
EPS(YoY)
0.66
130.64%
Analyst Rating
STRONG BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its total revenue reached 332.07M, with a year-on-year change of 51.09%.
What is the Earnings Per Share (EPS) of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 0.657, with a year-on-year change of 130.64%.
What is the net income of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its net income was 18.25M, with a year-on-year change of 131.75%.
What is the net margin of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its net profit margin was 5.49%, with a year-on-year change of 121.01%.
What is the gross margin of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its gross margin was 78.53%, with a year-on-year change of 4.10%.
What is the debt-to-asset ratio of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its debt-to-asset ratio was 1.96%, with a year-on-year change of 9174.27%.
What is the Return on Equity (ROE) of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its Return on Equity (ROE) was 4.31%, with a year-on-year change of 129.62%.
What is the Return on Assets (ROA) of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its Return on Assets (ROA) was 3.71%, with a year-on-year change of 129.04%.
What is the operating profit of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its operating profit was 8.67M, with a year-on-year change of 112.75%.
What are the current assets of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its current assets were 360.15M, with a year-on-year change of 21.82%.
What are the total assets of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its total assets of Castle Biosciences Inc were 531.24M, with a year-on-year change of 17.18%.
What are the total liabilities of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its total liabilities of Castle Biosciences Inc were 75.40M, with a year-on-year change of 21.47%.
What is the total equity of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its total equity of Castle Biosciences Inc was 455.83M, with a year-on-year change of 16.50%.
What is the net operating income of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its net operating income of Castle Biosciences Inc was 18.25M, with a year-on-year change of 131.75%.
What is the net investment of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its net investment of Castle Biosciences Inc was -50.14M, with a year-on-year change of -209.81%.
What is the net financing of Castle Biosciences Inc?
According to Castle Biosciences Inc's FY2024 earnings report, its net financing of Castle Biosciences Inc was 6.14M, with a year-on-year change of 367.15%.
